Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19

Detalles Bibliográficos
Autores principales: Hoffmann, Markus, Schroeder, Simon, Kleine-Weber, Hannah, Müller, Marcel A., Drosten, Christian, Pöhlmann, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269515/
https://www.ncbi.nlm.nih.gov/pubmed/32312781
http://dx.doi.org/10.1128/AAC.00754-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269515/
https://www.ncbi.nlm.nih.gov/pubmed/32312781
http://dx.doi.org/10.1128/AAC.00754-20

Ejemplares similares